rfXcel Named A Leader In Latest IDC Marketscape For Pharmaceutical Track And Trace Software Report

SAN RAMON, Calif.--(BUSINESS WIRE)--rfXcel, the leader in serialization, traceability, and DSCSA and global compliance in the private cloud for the Pharmaceutical and Life Sciences industries, today announced International Data Corporation (IDC), the premier global IT market research and advisory firm, has named it a “Leader” in the latest IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc #US40511116, March 2016). The report assesses vendors in the pharmaceutical track and trace software market.

“It’s great to have an objective third party provide validation to what our customers already know.”

Companies in the report are evaluated against several comprehensive criteria. Key strengths indicated by customers of rfXcel include customer-specific installations via private cloud technology, strong customer support, and application flexibility.

“rfXcel’s focus is on delivering for customers and the rfXcel solution provides what pharmaceutical companies need. Being named a ‘Leader’ in the IDC MarketScape report is wonderful recognition and certainly reinforces our industry leadership position and commitment to our customers,” said Glenn Abood, Founder and CEO of rfXcel. “It’s great to have an objective third party provide validation to what our customers already know.”

A Global Leader in Serialization, Traceability and Compliance

rfXcel is committed to delivering on its primary mission of securing the supply chain, enabling compliance with government regulations, improving patient safety and offering control and peace of mind for customers.

  • Secure the supply chain: rfXcel provides users the ability to track, trace and monitor pharmaceutical products throughout the supply chain, helping to curb and solve some of the pharmaceutical industry’s biggest issues such as theft, channel diversion, counterfeiting and safe handling. rfXcel also provides unit-level and hierarchy serialization for enhanced visibility and control of product throughout the supply chain.
  • Enable compliance with government regulations: rfXcel provides comprehensive U.S. Drug Supply Chain Security Act (DSCSA) and global compliance management solutions in one integrated platform to meet the most complex regulations and reporting requirements, giving users peace of mind and simplifying country-specific compliance needs. rfXcel is compliant with all GS1 standards and supports global, country-specific and any other custom format such as data formats specific to Brazil and China.
  • Improve patient safety: rfXcel provides users deep insight and allows monitoring of pharmaceutical products throughout the supply chain. The rfXcel Traceability System™ (rTS) can create, manage, allocate and store large volumes of individual and hierarchical serial numbers to provide visibility and control and help detect counterfeit drugs more easily. rfXcel also supports a mobile app to instantly authenticate and verify product validity using lots and/or serial numbers.
  • Control and Deliver Peace of Mind for Customers: The rfXcel solution is built on private cloud technology, which allows each customer system and implementation to be fully validated. Unlike other multi-tenant solutions running on public cloud technology, rfXcel private cloud technology is tailored to meet the unique specifications and requirements of each customer. It also enables each customer to be on their own version of the rfXcel solution, so there’s no application sharing or forced upgrades, giving customers more control, reliability and security.

About rfXcel

rfXcel Corporation, headquartered in San Ramon, CA, is a pioneer in creating Product Serialization, Traceability and Compliance private cloud solutions for the Life Sciences industry. Leading manufacturers, distributors, packagers, dispensers and retailers leverage rfXcel solutions to enable compliance with global government regulations, track and trace product throughout supply chains, and improve patient safety.

For more information, please visit www.rfxcel.com.

About IDC MarketScape

IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor's position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360 degree assessment of the strengths and weaknesses of current and prospective vendors.

Contacts

rfXcel Corp.
Jim Smiley, 925-395-6867
jsmiley@rfxcel.com

Back to news